Table: Torii Pharmaceutical - 9-MTH parent results
Oct 31 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2018 Sep 30, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 45.54 45.73 62.00
(-0.4 pct) (+4.5 pct) (-3.3 pct)
Operating 3.04 3.66 4.10
(-16.8 pct) (+42.2 pct) (-34.7 pct)
Recurring 3.13 3.74 4.20
(-16.1 pct) (+37.6 pct) (-34.4 pct)
Net 2.25 2.77 3.00
(-18.9 pct) (+57.9 pct) (-36.4 pct)
EPS 80.14 yen 98.83 yen 106.93 yen
EPS Diluted 80.14 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)